OncoSil Medical Limited (ASX: $OSL) Pancreatic cancer treatment device company, has announced its availability at eleven prestigious hospitals across Spain. This expansion signifies a significant step towards increased accessibility of this innovative treatment for cancer patients in the region. In the recently published half-yearly report, they said that in Spain a total of 20 patients have received treatment in clinical trials and commercial settings and they are continuously expanding by adding new sites. Recently big news was that 84 German hospitals received approval from the German Institute for the Hospital Remuneration System (InEK) to discuss funding for the OncoSil device under the innovation funding. Here are the details of the 11 hospitals in Spain in which OncoSil is available.